Literature DB >> 21251930

Yeast dihydroorotate dehydrogenase as a new selectable marker for Plasmodium falciparum transfection.

Suresh M Ganesan1, Joanne M Morrisey, Hangjun Ke, Heather J Painter, Kamal Laroiya, Margaret A Phillips, Pradipsinh K Rathod, Michael W Mather, Akhil B Vaidya.   

Abstract

Genetic manipulation of Plasmodium falciparum in culture through transfection has provided numerous insights into the molecular and cell biology of this parasite. The procedure is rather cumbersome, and is limited by the number of drug-resistant markers that can be used for selecting transfected parasites. Here we report a new selectable marker that could allow multiple transfections. We have taken advantage of our finding that a critical function of the mitochondrial electron transport chain (mtETC) in the erythrocytic stages of P. falciparum is the regeneration of ubiquinone as co-substrate of dihydroorotate dehydrogenase (DHODH), and that transgenic P. falciparum expressing ubiquinone-independent DHODH from yeast (yDHODH) are resistant to all mtETC inhibitors. We assessed the possibility of using yDHODH as a positive selectable marker for transfections of P. falciparum, including its use in gene disruption strategies. We constructed a transfection vector designed for gene disruption, termed pUF-1, containing the yDHODH gene as the positive selection marker in combination with a previously described fused yeast cytosine deaminase-uracil phosphoribosyl transferase gene as a negative selection marker. Transfection of the D10 strain followed by selection with atovaquone yielded positively selected parasites containing the plasmid, demonstrating that yDHODH can be used as a selective marker. Atovaquone, however, could not be used for such selection with the Dd2 strain of P. falciparum. On the other hand, we demonstrated that yDHODH transgenic parasites could be selected in both strains by Plasmodium DHODH-specific triazolopyrimidine-based inhibitors. Thus, selection with DHODH inhibitors was superior in that it successfully selected transgenic Dd2 parasites, as well as yielded transgenic parasites after a shorter period of selection. As a proof of concept, we have successfully disrupted the type II vacuolar proton-pumping pyrophosphatase gene (PfVP2) in P. falciparum by double crossover recombination, showing that this gene is not essential for the survival of blood stage parasites.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21251930      PMCID: PMC3057331          DOI: 10.1016/j.molbiopara.2011.01.004

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  16 in total

1.  Negative selection using yeast cytosine deaminase/uracil phosphoribosyl transferase in Plasmodium falciparum for targeted gene deletion by double crossover recombination.

Authors:  Alexander G Maier; Joanna A M Braks; Andrew P Waters; Alan F Cowman
Journal:  Mol Biochem Parasitol       Date:  2006-07-25       Impact factor: 1.759

2.  Conversion of dihydroorotate to orotate in parasitic protozoa.

Authors:  W E Gutteridge; D Dave; W H Richards
Journal:  Biochim Biophys Acta       Date:  1979-02-01

3.  Two classes of plant-like vacuolar-type H(+)-pyrophosphatases in malaria parasites.

Authors:  M T McIntosh; Y M Drozdowicz; K Laroiya; P A Rea; A B Vaidya
Journal:  Mol Biochem Parasitol       Date:  2001-05       Impact factor: 1.759

4.  Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil.

Authors:  D A Fidock; T E Wellems
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

5.  Circumsporozoite protein is required for development of malaria sporozoites in mosquitoes.

Authors:  R Ménard; A A Sultan; C Cortes; R Altszuler; M R van Dijk; C J Janse; A P Waters; R S Nussenzweig; V Nussenzweig
Journal:  Nature       Date:  1997-01-23       Impact factor: 49.962

6.  A set of independent selectable markers for transfection of the human malaria parasite Plasmodium falciparum.

Authors:  C B Mamoun; I Y Gluzman; S Goyard; S M Beverley; D E Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

7.  Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice.

Authors:  Ramesh Gujjar; Alka Marwaha; Farah El Mazouni; John White; Karen L White; Sharon Creason; David M Shackleford; Jeffrey Baldwin; William N Charman; Frederick S Buckner; Susan Charman; Pradipsinh K Rathod; Margaret A Phillips
Journal:  J Med Chem       Date:  2009-04-09       Impact factor: 7.446

8.  Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique.

Authors:  R E Desjardins; C J Canfield; J D Haynes; J D Chulay
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

9.  Genome sequence of the human malaria parasite Plasmodium falciparum.

Authors:  Malcolm J Gardner; Neil Hall; Eula Fung; Owen White; Matthew Berriman; Richard W Hyman; Jane M Carlton; Arnab Pain; Karen E Nelson; Sharen Bowman; Ian T Paulsen; Keith James; Jonathan A Eisen; Kim Rutherford; Steven L Salzberg; Alister Craig; Sue Kyes; Man-Suen Chan; Vishvanath Nene; Shamira J Shallom; Bernard Suh; Jeremy Peterson; Sam Angiuoli; Mihaela Pertea; Jonathan Allen; Jeremy Selengut; Daniel Haft; Michael W Mather; Akhil B Vaidya; David M A Martin; Alan H Fairlamb; Martin J Fraunholz; David S Roos; Stuart A Ralph; Geoffrey I McFadden; Leda M Cummings; G Mani Subramanian; Chris Mungall; J Craig Venter; Daniel J Carucci; Stephen L Hoffman; Chris Newbold; Ronald W Davis; Claire M Fraser; Bart Barrell
Journal:  Nature       Date:  2002-10-03       Impact factor: 49.962

10.  Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii.

Authors:  Jane M Carlton; Samuel V Angiuoli; Bernard B Suh; Taco W Kooij; Mihaela Pertea; Joana C Silva; Maria D Ermolaeva; Jonathan E Allen; Jeremy D Selengut; Hean L Koo; Jeremy D Peterson; Mihai Pop; Daniel S Kosack; Martin F Shumway; Shelby L Bidwell; Shamira J Shallom; Susan E van Aken; Steven B Riedmuller; Tamara V Feldblyum; Jennifer K Cho; John Quackenbush; Martha Sedegah; Azadeh Shoaibi; Leda M Cummings; Laurence Florens; John R Yates; J Dale Raine; Robert E Sinden; Michael A Harris; Deirdre A Cunningham; Peter R Preiser; Lawrence W Bergman; Akhil B Vaidya; Leo H van Lin; Chris J Janse; Andrew P Waters; Hamilton O Smith; Owen R White; Steven L Salzberg; J Craig Venter; Claire M Fraser; Stephen L Hoffman; Malcolm J Gardner; Daniel J Carucci
Journal:  Nature       Date:  2002-10-03       Impact factor: 49.962

View more
  53 in total

1.  Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice.

Authors:  Ramesh Gujjar; Farah El Mazouni; Karen L White; John White; Sharon Creason; David M Shackleford; Xiaoyi Deng; William N Charman; Ian Bathurst; Jeremy Burrows; David M Floyd; David Matthews; Frederick S Buckner; Susan A Charman; Margaret A Phillips; Pradipsinh K Rathod
Journal:  J Med Chem       Date:  2011-05-12       Impact factor: 7.446

2.  Mitochondrial RNA polymerase is an essential enzyme in erythrocytic stages of Plasmodium falciparum.

Authors:  Hangjun Ke; Joanne M Morrisey; Suresh M Ganesan; Michael W Mather; Akhil B Vaidya
Journal:  Mol Biochem Parasitol       Date:  2012-05-26       Impact factor: 1.759

3.  Plasmodium Niemann-Pick type C1-related protein is a druggable target required for parasite membrane homeostasis.

Authors:  Eva S Istvan; Sudipta Das; Suyash Bhatnagar; Josh R Beck; Edward Owen; Manuel Llinas; Suresh M Ganesan; Jacquin C Niles; Elizabeth Winzeler; Akhil B Vaidya; Daniel E Goldberg
Journal:  Elife       Date:  2019-03-19       Impact factor: 8.140

Review 4.  Advances in molecular genetic systems in malaria.

Authors:  Tania F de Koning-Ward; Paul R Gilson; Brendan S Crabb
Journal:  Nat Rev Microbiol       Date:  2015-06       Impact factor: 60.633

5.  ATP synthase complex of Plasmodium falciparum: dimeric assembly in mitochondrial membranes and resistance to genetic disruption.

Authors:  Praveen Balabaskaran Nina; Joanne M Morrisey; Suresh M Ganesan; Hangjun Ke; April M Pershing; Michael W Mather; Akhil B Vaidya
Journal:  J Biol Chem       Date:  2011-10-07       Impact factor: 5.157

6.  Kinase-associated endopeptidase 1 (Kae1) participates in an atypical ribosome-associated complex in the apicoplast of Plasmodium falciparum.

Authors:  Jeremy P Mallari; Anna Oksman; Barbara Vaupel; Daniel E Goldberg
Journal:  J Biol Chem       Date:  2014-09-09       Impact factor: 5.157

7.  A Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Improved Drug-like Properties for Treatment and Prevention of Malaria.

Authors:  Margaret A Phillips; Karen L White; Sreekanth Kokkonda; Xiaoyi Deng; John White; Farah El Mazouni; Kennan Marsh; Diana R Tomchick; Krishne Manjalanagara; Kakali Rani Rudra; Grennady Wirjanata; Rintis Noviyanti; Ric N Price; Jutta Marfurt; David M Shackleford; Francis C K Chiu; Michael Campbell; Maria Belen Jimenez-Diaz; Santiago Ferrer Bazaga; Iñigo Angulo-Barturen; Maria Santos Martinez; Maria Lafuente-Monasterio; Werner Kaminsky; Kigbafori Silue; Anne-Marie Zeeman; Clemens Kocken; Didier Leroy; Benjamin Blasco; Emilie Rossignol; Thomas Rueckle; Dave Matthews; Jeremy N Burrows; David Waterson; Michael J Palmer; Pradipsinh K Rathod; Susan A Charman
Journal:  ACS Infect Dis       Date:  2016-10-04       Impact factor: 5.084

Review 8.  Towards genome-wide experimental genetics in the in vivo malaria model parasite Plasmodium berghei.

Authors:  Joachim M Matz; Taco W A Kooij
Journal:  Pathog Glob Health       Date:  2015-03-19       Impact factor: 2.894

9.  Inhibition of cytochrome bc1 as a strategy for single-dose, multi-stage antimalarial therapy.

Authors:  Allison M Stickles; Li-Min Ting; Joanne M Morrisey; Yuexin Li; Michael W Mather; Erin Meermeier; April M Pershing; Isaac P Forquer; Galen P Miley; Sovitj Pou; Rolf W Winter; David J Hinrichs; Jane X Kelly; Kami Kim; Akhil B Vaidya; Michael K Riscoe; Aaron Nilsen
Journal:  Am J Trop Med Hyg       Date:  2015-04-27       Impact factor: 2.345

10.  Lead Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series for the Treatment of Malaria.

Authors:  Sreekanth Kokkonda; Xiaoyi Deng; Karen L White; Farah El Mazouni; John White; David M Shackleford; Kasiram Katneni; Francis C K Chiu; Helena Barker; Jenna McLaren; Elly Crighton; Gong Chen; Inigo Angulo-Barturen; Maria Belen Jimenez-Diaz; Santiago Ferrer; Leticia Huertas-Valentin; Maria Santos Martinez-Martinez; Maria Jose Lafuente-Monasterio; Rajesh Chittimalla; Shatrughan P Shahi; Sergio Wittlin; David Waterson; Jeremy N Burrows; Dave Matthews; Diana Tomchick; Pradipsinh K Rathod; Michael J Palmer; Susan A Charman; Margaret A Phillips
Journal:  J Med Chem       Date:  2020-04-16       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.